| Line Item | 2025-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | -1.1% | — |
| Cost of Revenue | $1.2M | -21.9% | — |
| Gross Profit | $1.3M | +29.3% | — |
| R&D Expense | $8K | -88.0% | — |
| SG&A Expense | $435K | +14.8% | — |
| Operating Income | $553K | +4.8% | — |
| Interest Expense | $7K | +116.4% | — |
| Pre-tax Income | $543K | +12.7% | — |
| Income Tax | $139K | -18.6% | — |
| Net Income | $403K | +30.0% | — |
| EPS (Basic) | $0.03 | +0.0% | — |
| Line Item | 2025-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.6M | +163.2% | +343.0% |
| Inventory | $988K | -14.2% | +14.5% |
| Current Assets | $6.4M | +30.5% | +46.7% |
| Total Assets | $6.8M | +27.0% | +41.7% |
| Current Liabilities | $1.5M | +2.0% | +81.9% |
| Total Liabilities | $2.5M | +0.1% |
| Line Item | 2025-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.0M | — | — |
| Capital Expenditures | $90K | — | — |
| Investing Cash Flow | -$90K | — | — |
| Financing Cash Flow | -$983K | — | — |
| Free Cash Flow | $937K | — | — |
| -3.8% |
| Stockholders' Equity | $4.3M | +51.1% | +97.1% |